Identification | Back Directory | [Name]
1-(2-(tetrahydro-2H-pyran-2-yloxy)ethyl)-1H-4-pyrazole boronic acid pinacol ester | [CAS]
1040377-08-9 | [Synonyms]
2-(4-(4,4,5,5-TetramethyL 2-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl) 1-(hydroxyethyl)pyrazole-4-boronic acid pinacol ester 1-(2-Hydroxyethyl)-1H-pyrazole-4-boronic acid, pinacol ester pyran-2-yloxy)ethyl)-1H-4-pyrazole boronic acid pinacol ester (1-(2-HYDROXYETHYL)-1H-PYRAZOL-4-YL)BORONIC ACID PINACOL ESTER 1-(2-Hydroxyethyl)-1H-pyrazole-4-boronic acid, pinacol ester 95% 4-(4,4,5,5-TetraMethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole-1-ethanol 2-[4-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]ethan-1-ol 2-[4-(4,4,5,5-Tetramethyl-[1,3,2]dioxaborolan-2-yl)pyrazol-1-yl]ethanol 1H-Pyrazole-1-ethanol, 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)- 2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)ethan 2-(4-(4,4,5,5-TetraMethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)ethanol 2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)ethan-1-ol 1-(2-(tetrahydro-2H-pyran-2-yloxy)ethyl)-1H-4-pyrazole boronic acid picol ester 1-(2-(tetrahydro-2H-pyran-2-yloxy)ethyl)-1H-4-pyrazole boronic acid pinacol este 1-(2-(tetrahydro-2H-pyran-2-yloxy)ethyl)-1H-4-pyrazole boronic acid pinacol ester 2-[4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]ethan-1-ol, 1-Hydroxy-2-[4-(4,4,5,5-tetrameth 2-[4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]ethan-1-ol, 1-Hydroxy-2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]ethane | [Molecular Formula]
C11H19BN2O3 | [MDL Number]
MFCD12033564 | [MOL File]
1040377-08-9.mol | [Molecular Weight]
238.09 |
Chemical Properties | Back Directory | [Boiling point ]
379.4±22.0 °C(Predicted) | [density ]
1.13±0.1 g/cm3(Predicted) | [storage temp. ]
Inert atmosphere,Store in freezer, under -20°C | [pka]
14.47±0.10(Predicted) |
Hazard Information | Back Directory | [Uses]
4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole-1-ethanol, can be used in the synthesis of series of aminopyridines with substituted benzoxazoles, acting c-Met kinase inhibitors. |
|
|